Abstract Excessive bleeding after cardiopulmonary bypass (CPB) is risk factor for adverse outcomes after elective cardiac surgery (ECS). Differentiating between patients who bleed due to surgical issues and those whose excessive chest tube output (CTO) is due to coagulopathy, remains challenging. Bedside suitable tests to identify hemostatic disturbances and predict excessive bleeding are desirable. The study sought to evaluate prediction of excessive bleeding after ECS using two bedside suitable devices for platelet function and viscoelastic blood clot properties assessment. We enrolled 148 patients (105 male and 43 female) undergoing ECS in a prospective observational study. Patients were characterized as bleeders if their 24 h CTO exceeded the 75th percentile of distribution. Multiple electrode aggregometry (MEA, with ASPI, ADP and the TRAP test) and rotational thromboelastometry (TEM, with ExTEM, HepTEM and FibTEM test), were performed at three time points: preoperatively (T1), during CPB (T2), and after protamine administration (T3). The primary endpoint was CTO and the secondary endpoint was administration of blood products, 30-day and 1 year mortality. The best predictors of increased bleeding tendency were the tests performed after protamine administration (T3). 
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Disturbances of coagulation consequent to CPB have a multifactorial etiology, such as loss of platelet reactivity, coagulation factor consumption, hemodilution due to the CPB priming procedure etc. [7] . Extracorporeal circulation and heparin may induce many abnormalities in the coagulation system, including thrombocytopenia [2] , platelet dysfunction [8, 9] , coagulation factor deficiencies [10] , residual heparin after protamine administration [11] , and fibrinolysis [12] . Microvascular bleeding caused by dysfunctional platelets and an impaired coagulation cascade occur after CPB secondary to foreign surface contact [13] . Impaired platelets removed from the CPB circuit are presumed to be dysfunctional and are jointly responsible for postoperative bleeding [13] .
However, the question ''How to predict and prevent excessive postoperative bleeding?'' remains challenging. Differentiating between coagulopathy and inadequate surgical hemostasis as a cause for bleeding after CPB is sometimes difficult. Identifying abnormal alteration of platelet function and coagulation tests prior to and after CPB may make the important differentiation between coagulopathic (nonsurgical) bleeding requiring procoagulant blood components transfusion and surgical bleeding requiring surgical intervention. Reliable methods to predict patients with higher risk of coagulation impairments are lacking [14] . Conventional coagulation tests are not able to predict postoperative bleeding [15, 16] . ''Blind'' transfusion therapy with multiple blood products still occurs when bleeding is excessive, and transfusion of allogeneic blood products expose patients to multiple risks and increased expenses [4-6, 17, 18] . The bedside suitable tests with capability for differentiating bleeders from nonbleeders would be useful in creating a transfusion algorithm to guide blood product targeted therapy. Rotation thromboelastometry (TEM) performed on whole blood samples provides information on the contribution of fibrinogen and platelets to clot formation. A significant reduction in the number of blood transfusions and mediastinal re-exploration for hemorrhage in cardiac surgery patients after institution of thromboelastography-guided blood product administration is described in retrospective study by Spiess et al. [19] .
Despite the fact that thromboelastometry use resulted in procoagulant blood products administration reduction, the precise relationship between thromboelastometry values and postoperative bleeding still remains unclear. Although obtaining evidence about the global coagulation cascade, this method is inaccurate for detecting isolated platelet dysfunction. Therefore, it seems that simultaneous use of TEM and platelet function assay could offer a comprehensive insight into the hemostatic properties. Multiple electrode aggregometry (MEA) uses the technique of whole blood aggregometry and quantifies platelet function by attachment of platelets activated with different stimulants onto metal electrodes leading to increase of electrical impedance.
This study sought to evaluate whether perioperative viscoelastic blood properties and platelet function measurements in three intraoperative measurement time points using concomitant TEM and MEA can identify patients with increased bleeding risk as measured by postoperative blood loss. We were also interested to determine whether above mentioned two Point of Care (POC) devices can predict patients at enhanced risk of blood products administration due to excessive blood loss. We hypothesized that MEA and TEM could detect patients with higher risk of excessive postoperative bleeding and transfusion requirements.
Patients and methods

Patient selection
This prospective observational study was approved by the Institutional Research Ethics Review Board and registered at the Clinical-trials.gov website (Identifier NCT01281397). Type and daily dose of antiplatelet therapy (APT), received preoperatively, and the interval from the last dose of clopidogrel (CLO) to surgical procedure was documented.
After approval by the local Medical University and University Hospital Center Ethics Committee and written informed consent, 148 consecutive patients (male, n = 105 (70.9 %); female, n = 43 (21.9 %)), scheduled for elective cardiac surgery (ECS) procedures requiring CPB between July 2010 and January 2011 were prospectively studied. Criteria for excluding patients from the group of subjects were: age younger than 18 years, urgent procedure, patients with off-pump cardiac surgical procedure, on APT other than Aspirin (ASA) and CLO, patients with inaccurate APT administration documentation, urgent surgery, and patients requiring surgical exploration for excessive bleeding due to obvious surgical bleeding with a bleeding vessel identified.
Bleeding risk assessment 515
In our study cohort APT was administered by the referral cardiologist. If patients were admitted to Department of Cardiac Surgery with a daily dose of 100 mg ASA, the drug was continued up to the day of surgery. If patients were admitted with a daily dose of 75 mg CLO, either alone or in addition to ASA, CLO was discontinued at Department of Cardiac Surgery prior to surgery with different time intervals from CLO cessation to surgery, from 2 to 8 days, respectively. Time from CLO cessation to surgery varied individually, based on the date of admission to Department of Cardiac Surgery and the date of the procedure. Patients received APT continuously for at least 10 days prior to admission to our department.
Perioperative management
All patients had the same anesthetic and perfusion teams, and were admitted at least 1 day before surgery. Surgery was performed by using a standard technique. Surgical approach in all cases was through median sternotomy. All measurements were performed by research fellow, not directly included in treating patients. The nurses, anesthesiologists, and surgeons managing the patient's care were blinded to the both, TEM and MEA results. Surgery was performed in a single unit with standard surgical techniques. Surgical bleeding was controlled with diathermy and bone wax.
Cardiopulmonary circuit consisted of the Medtronic Affinity Trillium membrane oxygenator, venous reservoir and PVC tubing (Medtronic, Minneapolis, MN, USA) and a Stoeckert III roller pump (Stoeckert, Munich, Germany). Flow at 2.2/l/min/m 2 and mean blood pressure of 60 mmHg were targeted. Heart was arrested with cold blood cardioplegia. Systemic heparinisation aiming at an activated clotting time (ACT) [480 s was used, followed by full reversal with protamine after decannulation. A dose of 1 g tranexamic acid was given at the induction of anesthesia and after protamine administration. Inotropic support was initiated in order to maintain a cardiac index greater than 2.2/l/min/m 2 . Weaning from CPB was initiated once the patient's rhythm had stabilized and normothermia had been achieved. Cardiotomy suction returned blood to the CPB circuit. Packed red blood cells (PRBC) were transfused if hematocrit was \20 % during CPB and \25 % after terminating CPB, or when significant bleeding was obvious. Volume replacement in the intensive care unit was administered as deemed necessary by the attending physician using hydroxyethyl starch 6 % 130/0.4 and lactated Ringer's solution, PRBC's were transfused if deemed necessary by the consultant anesthesiologist.
Fresh frozen plasma (FFP) was given in cases showing prolonged prothrombin time (less than 45 %), or according to clinical decision by the consultant anesthesiologist.
Fibrinogen cryoprecipitate and platelet transfusion were administered in cases of excessive bleeding at discretion of consultant anesthesiologist.
Blood sampling
Blood samples for MEA and TEM measurements were obtained at three time points on day of surgery via central venous port. For MEA tests blood was collected in 4 ml heparin (Lithium Heparin 68 I.U.) coated BD Vacutainer Ò plastic tubes. For TEM test blood was collected in 1.8 mL sodium citrate (0.109Molar/3.2 % citrate concentration) Vacutainer Ò plastic tubes. Routine laboratory tests were performed each day from day before surgery to fourth postoperative day. The same person, not directly involved in patient care, performed all measurements. Blood samples for MEA were at rest for 30 min after blood withdrawal and MEA was performed subsequently. TEM tests were performed immediately after blood withdrawal.
To assess changes in viscoelastic blood properties and platelet function before, during and after CPB, samples were drawn before induction of anesthesia (T1), after release of aortic clamp (T2), and 15 min after heparin neutralization (T3).
We used two POC devices for platelet function assessment and for monitoring of viscoelastic properties of blood clot.
Multiple electrode aggregometry (MEA)
Whole blood aggregation was determined using a new generation impedance aggregometer (Multiplate Ò analyzer, Dynabyte Medical, Munich). Detailed description of method has already been published [20] . Put briefly, MEA is based on the principle that blood platelets are nonthrombogenic in their resting state, but expose receptors on their surface when they get activated, which allow them to attach on vascular injuries and artificial surfaces. When platelets stick on the Multiplate sensor wires, they enhance the electrical resistance between them, which is continuously recorded. Increase in impedance is expressed in arbitrary area under curve (AUC) units, highlighted as the parameter with the highest diagnostic power [20, 21] . Platelet aggregation was determined in response to stimulation with arachidonic acid with a final concentration of 0.5 mM (ASPI test designed to evaluate ASA effect), adenosine diphosphate (ADP) with a final concentration of 6.4 lM (ADP test designed to evaluate thienopyridines, such as CLO, effect) and thrombin receptor-activating peptide (TRAP-6), TRAP test, 32-lM final concentration. The TRAP test is sensitive to GPIIb-IIIa inhibitors only, and in absence of these drugs, represents the ''natural'' aggregation potential of the platelets.
Modified rotational thromboelastometry (TEM)
TEM was performed according to the manufacturer' instruction using equipment and kits provided by TEM International GmbH, Munich, Germany. The following kits were used: intrinsically activated coagulation (InTEM) and extrinsically activated coagulation (ExTEM), which induce clot formation via the intrinsic pathway or the extrinsic, tissue-factor-dependent pathway, respectively; HepTEM assay (heparinase modified TEM), coagulation is triggered via the intrinsic pathway. FibTEM, a test measuring the contribution of fibrinogen, which is based on ExTEM but contains cytochalasin D to inhibit the contribution of platelets in order to give a measure for the contribution of fibrinogen to clot firmness. By digital data processing, the following typical variables are obtained: clotting time (CT), the time from the start of measurement until the onset of clotting; Clot formation time (CFT), the time between the onset of clotting and the moment when the clot firmness reaches an amplitude of 20 mm; A 10, A 20, A 30 corresponds to the maximum amplitude of the curve after 10, 20 and 30 min, respectively.
Primary and secondary outcome definition and evaluation CTO was determined as study's primary outcome. To estimate blood loss, we meticulously documented CTO, in first 24 postoperative hours and divided it by patient's weight. Drainage loss was assessed after completion of a 30-min stabilization period. Blood loss during the stabilization period was not included in the definition of postoperative hemorrhage. Such loss may be caused by postural changes when transferring the patient from the operating room table to the bed or because of fluid in the pleural or mediastinal cavity, which may have arisen from the rinsing with water as an attempt to achieve surgical hemostasis. Intraoperative and postoperative transfusion requirements (PRBC in mL, FFP in mL, fibrinogen cryoprecipitate in grams and platelet concentrates in units) were determined as study's secondary outcome. Surgical reexploration of the mediastinum for excessive bleeding was noted, along with any surgical explanation for the bleeding.
Although some authors offer definitions of abnormal blood loss [16] , we decided to make our own definition in order to adapt the volume of postoperative CTO to our study cohort. We believe that such a definition makes the most reliable correlation, and is not distorted to different perfusionistic, surgical and anesthetic techniques described by other authors. Postoperative CTO was recorded for the first 24 postoperative hours and divided by the patient's weight. Patients were characterized as bleeders if their 24 h CTO (ml/kg) exceeded [ 75th percentile of distribution.
A similar definition has already been described in the literature [22] . MEA and TEM variables were correlated to 24 h CTO (ml/kg). Patients were divided with respect to presence of excessive bleeding, and MEA and TEM variables were compared between groups.
Statistical analysis
The Kolmogorov-Smirnov test was used for evaluating the normality of distribution of all continuous variables. Correlation between CTO during the first postoperative 24 h and MEA parameters was evaluated by Spearman's correlation coefficient. Mann-Whitney U test was used to evaluate whether the medians on a test variables differ significantly between two groups. Chi-square statistic test was used to compare a frequency distribution of observed categoric variables between the two groups. Receiver operating characteristic curve (ROC) was constructed to assess the ability of MEA and TEM parameters to predict excessive postoperative blood loss [23] . A value of p \ 0.05 was considered statistically significant. For statistical analysis we used MedCalc Ò For Windows (MedCalc Software, Broekstraat 52, 9030 Mariakerke, Belgium).
Results
All patients from sample were discharged from hospital. 24 h CTO value of 12.46 ml/kg presented 75th percentile of distribution, thus cut off value for ''bleeder category''. The cohort group was divided into two subgroups according to occurrence of excessive postoperative bleeding. Patient's demographic, surgical, and baseline routine laboratory findings are presented in Tables 1 and 2 . Differences in clinical and transfusion outcomes of patient groups according to bleeding tendency are presented in Table 3 . Higher proportion of patients in ''bleeder'' category were preoperatively exposed to CLO (43.2 vs. 22.5 %, p = 0.015, Table 2 ). For patients exposed to CLO preoperatively, we observed shorter timeframe from clopidogel discontinuation to surgery in ''bleeder'' group (4 vs. 6 days, p = 0.024).
Two groups according to excessive bleeding occurrence were compared for clinical and transfusion outcomes (Table 3 ). In ,,excessive ''bleeding'' subgroup, higher proportion of patients were transfused with fresh frozen plasma (43.2 vs. 12.6 %, p \ 0.001), fibrinogen concentrate (24. At T2, significant differences between groups were found for MEA ASPI and ADP test values, as well as for HepTEM, ExTEM and FibTEM variables ( Table 5) .
The best predictors of increased bleeding tendency were the tests performed after protamine administration (T3) ( Table 6) At T3, both the MEA and TEM tests with the strongest correlations to 24 h CTO were tested for accuracy in predicting excessive postoperative bleeding using ROC analysis. The accuracy of the ASPI test (AUC 0.636, p = 0.008) is shown in Fig. 1 , the accuracy of the ADP test (AUC 0.667, p = 0.001) is shown in Fig. 2 , the accuracy of the ExTEM alfa (AUC 0.691, p \ 0.001) is shown in Fig. 3 , the accuracy of the FibTEM A 30 (AUC 0.695, p \ 0.001) is shown in Fig. 4 , and the accuracy of the HepTEM A 30 (AUC 0.663, p = 0.002) is shown in Fig. 5 . We used ACT test regularly Bleeding risk assessment 519 after protamine administration. We compared ACT values between groups with respect to bleeding tendency and we found non-significant differences between groups (median 137 vs. 138 s, p = 0.755). In addition to, ACT value did not correlate to value of 24 h chest tube output (Spearman's correlation coefficient -0.002, p = 0.976).
Discussion
Our study showed that MEA and TEM are useful methods for prediction of excessive bleeding after ECS. The best predictors of increased bleeding tendency were the tests performed after protamine administration (T3). One reason for such results is the fact that the effect of CPB on platelet function and viscoelastic blood properties and the consequent risk of bleeding were not explored in T1. Hemostatic impairment after CPB is complex in nature due to many components of the hemostatic system involved in. In addition to insufficient surgical hemostasis, bleeding after CPB may be induced by many abnormalities in the coagulation system. Conventional laboratory tests are unable to decompose multifactorial coagulopathy pathogenesis as described by Paparella et al. [24] . Impaired platelet function is thought to be the most common coagulation defect associated with CPB [2, 25] . In the absence of platelet mapping, both thromboelastometry and thromboelastography are poor indicators of impaired platelet function. Thus, concurrent use of both modified rotational thromboelastometry (TEM) and MEA should be the best show of hemostatic properties of blood.
Literature review
Conflicting data have been reported regarding ability of point-of-care clotting assays and platelet function assays to predict bleeding after cardiac surgery procedures. Essell et al. [26] compared conventional thromboelastography to conventional coagulation tests. Whilst the bleeding time and platelet count had sensitivities similar to thromboelastography, thromboelastography specificity was greater. In addition, they suggested that patients with abnormal thromboelastography were at increased risk of bleeding but the excessive bleeding in the face of a normal thromboelastography implied surgical bleeding and FFP and platelets should not simply be used empirically [26] .
Analyzing patients with coronary artery bypass surgery (CABG), Ti et al. [16] found moderate correlation between thromboelastography parameters, total blood loss and blood product requirements in ''bleeders'' cohort subgroup. The major drawback of this study was the fact only CABG surgery patients were evaluated. CABG surgery patients differ from patients undergoing ''other than isolated CABG'' surgery in the use of anticoagulants, length of CPB, age of patients and preoperative status. Mengistu et al. [14] showed that patients requiring postoperative blood transfusion showed lower preoperative ADP-mediated aggregometry compared with nontransfused patients, Table 4 Comparison of the multiple electrode aggregometry and rotational thromboelastometry results between groups with respect to bleeding tendency and correlations of parameters with 24 h chest tube output (ml/kg)
T1
According to 24 h chest tube output (ml/kg) CTO [27] . Our results suggest similar phenomenon for ADP test values in T2 (Spearman r = -0.230, p = 0.005) and T3 (Spearman r = -0.299, p \ 0.001), but not in T1 time point where ADP test value did not correlate to CTO volume (Spearman r = S0.095, p = 0.252). Ray et al. [28] reported extensive bleeding in patients with reduced preoperative platelet aggregation. This report is only partially in line with our results. Preoperatively (T1) significant differences between groups with respect to bleeding tendency were found for MEA ASPI test (Median 20 vs. 40 AUC, p = 0.043), but not for ADP and TRAP test. In contrast to our results, several studies found no correlation between clotting assays and bleeding outcomes. Nutall et al. [29] described post CPB bleeding prediction using thrombelastography. The thromboelastography values that were most sensitive and specific for differentiating bleeding from nonbleeding patients were within the normal range for thromboelastography. The major drawback was the fact that patients were characterized as bleeder by Results of tests are during cardiopulmonary bypass after aortic cross clamp removal subjective designation of the surgical field by anesthesiologist and surgeon. Of note, the thromboelastography values did not correlate with blood loss. Dorman et al. [30] did not find significant relationship between thromboelastography variables and blood losses. Wang et al. [31] described similar results with lack of any correlation between thromboelastography variables and postoperative blood loss. Ostrowski et al. [32] described correlation between preoperative thromboelastography data and blood product usage, but there was no correlation between thromboelastography data and chest tube drainage. Cammerer et al. [22] reported risk stratification of patients with increased bleeding tendency by maximal clot firmness and alphaangle, but low positive predictive values did not allow clinical application.
Conclusion
In order to prevent excessive postoperative CTO, hemostatic interventions with timely and targeted blood component therapy according to MEA and TEM results should be considered. TEM can be used to predict bleeding in cardiac surgery, but it can also be used to guide targeted blood products transfusion algorithms where its use had been associated with significant decreases in blood products administration [33] .
The inconsistent results that were obtained in the various studies could be due to differences in the TEM and thromboelastography tests that were applied (i.e. clotting activation via intrinsic or extrinsic pathway), concentration of the stimuli, as well, as due to differences in the recording time of blood loss [34, 35] . The definition of what constitutes abnormal postoperative bleeding is difficult. Although blood loss is a continuous variable, a separation of normal and abnormal bleeding based on single numerical value is necessary to allow meaningful comparisons with previous studies. Ti et al. [16] described the drawbacks of chest tube output quantification. Blood loss measured from the chest and mediastinal tubes consists of a mixture of fluids, including actual blood loss, serous drainage, and fluid left in the pleural cavity. Also, the actual blood loss through these tubes is the sum of coagulopathic bleeding and surgical bleeding from wound edges which may partially explain low specificity values as obtained by ROC analysis. In present study, drainage loss was assessed after completion of a 30-min stabilization period. Blood loss during the stabilization period may be caused by postural changes when transferring the patient from the operating room table to the bed or because of fluid in the pleural or mediastinal cavity, which may have arisen from the rinsing with water as an attempt to achieve surgical hemostasis. We decided to monitor chest tube output in first 24 h after surgery. Drainage loss after this period was not considered to be of ''hemostatic disturbances'' origin, because it most likely originates from a surgical source (e.g., detached arterial clip). Concerning serous drainage, chest output observed in the first 24 postoperative hours in present study was never clear and serous, but sanguinary and accompanied with the drop in hemoglobin levels, thus indicating hemorrhage. Standard goal-directed restrictive fluid therapy was employed in all cases. When executed meticulously, as it is in our institution, it is unlikely to reduce albumin to a level that could be connected with such a significant decline in colloid osmotic pressure in patients with preoperatively normal protein level (measuring protein level is a part of routine preprocedural panel of tests, albumin level is not). In our study the attending clinicians, both the anesthesiologists and surgeons were blinded to MEA and TEM results, therefore administering procoagulant blood products mainly on the clinical grounds. The use of procoagulant blood products certainly affected the number of bleeders and amount of bleeding. This decrease in amount of bleeding would reduce the degree of correlation between blood loss and both MEA and TEM parameters by increasing the number of false-negative results, and reducing the sensitivity of MEA and TEM parameters. Finally, MEA and TEM are useful in distinguishing patients by excessive bleeding and provide correlations with CTO. Values above the cut-off values do not imply the fact that the patients will not bleed, however they may advise to pay attention to surgical cause of bleeding. Hemostatic management algorithm with the timely and targeted procoagulant blood component therapy administration according to MEA and TEM should be evaluated in context of outcomes such as mortality, bleeding and transfusion requirements. 
